Bon Natural Life Limited

BON ·Healthcare, Drug Manufacturers - General, China
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Operating Activities
Net Income $-2.0M $398.2K $4.6M $6.2M $4.6M $3.0M $2.6M
Depreciation & Amortization $1.1M $1.1M $954.5K $218.5K $228.5K $230.6K $226.6K
Depreciation $1.0M $1.1M $945.5K $210.9K $219.9K $226.5K $222.5K
Amortization $38.7K $24.1K $9.0K $7.6K $8.6K $4.1K —
Stock-Based Compensation $1.4M $1.3M $349.4K $170.9K $422.2K $211.1K —
Net Cash from Operating Activities $141.1K $-7.7M $-616.9K $-187.1K $4.1M $2.6M $7.1M
Investing Activities
Capital Expenditures $6.8K $7.0K $61.9K $27.7K $51.9K $31.9K $213.6K
Business Acquisitions — — — — — — —
Net Cash from Investing Activities $-10.0M $-15.7K $-1.2M $-3.1M $-7.4M $-3.0M $-8.4M
Financing Activities
Dividends Paid — — — — — — —
Stock Repurchases — — — — — — —
Net Cash from Financing Activities $15.5M $8.8M $1.2M $2.3M $5.4M $112.5K $804.7K
Net Change in Cash $5.6M $545.9K $-728.1K $-1.1M $1.9M $-240.7K $-527.1K
Free Cash Flow $134.3K $-7.7M $-678.8K $-214.8K $4.0M $2.6M $6.9M